35
Views
0
CrossRef citations to date
0
Altmetric
Articles

Development and Validation of Bioanalytical Method for Simultaneous Estimation of Leucovorin and its Primary Metabolite 5-Methyl Tetrahydrofolic Acid from Human Plasma by Liquid Chromatography Tandem Mass Spectrometry with Solid Phase Extraction

, , &
Pages 590-601 | Received 04 Jul 2020, Accepted 12 Sep 2020, Published online: 23 Dec 2020
 

Abstract

A simple, highly sensitive, precise and accurate liquid chromatographic mass spectroscopic (LC-MS/MS) method has been developed and validated for simultaneous quantification of Leucovorin and its metabolite 5-Methyl tetrahydrofolic acid in human plasma using Leucovorin-d4 and 5-Methyl-d3 tetrahydrofolic acid as internal standard (IS), respectively. The analytes were extracted from human plasma by solid phase extraction (SPE) technique using ion exchange cartridges. Chromatographic separation was achieved with reversed phase column chromatography. API 5500 LC-MS/MS in multiple reactions monitoring (MRM) was used for detection. Obtained results revealed that the method had a short sample preparation time as well as a chromatographic run time of just 3.0 min. In summary our results suggest that the validated method fulfilled all preset criteria for sensitivity, specificity, linearity (5.0-700.0 ng/mL), inter-and intra-accuracy and precision for both molecules.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.